New American Therapeutics - ZONTIVITY - Ownership and Business Overview

Life ScienceCompany

New American Therapeutics - ZONTIVITY Ownership

Who owns New American Therapeutics - ZONTIVITY?

New American Therapeutics - ZONTIVITY is owned by Legacy-Xspire Holdings. It was acquired on September 3, 2020.

New American Therapeutics - ZONTIVITY Business Overview

Where is New American Therapeutics - ZONTIVITY headquartered?

New American Therapeutics - ZONTIVITY is headquartered in Parsippany, New Jersey.

What sector is New American Therapeutics - ZONTIVITY in?

New American Therapeutics - ZONTIVITY is a life science company.

Life Science M&A Summary in 2020

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.

Join Mergr to view all 290 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 267 by strategics.

New American Therapeutics - ZONTIVITY

Parsippany, New Jersey 07054
United States,

ZONTIVITY is a prescription medicine used to treat people who have had a heart attack or reduced blood flow in their legs (peripheral artery disease). ZONTIVITY is used with aspirin and/or clopidogrel to lower your chance of having another serious problem with your heart or blood vessels, such as heart attack, stroke, or death.


 Subscribe to unlock this and 208,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.